616P Osimertinib after definitive chemoradiotherapy (CRT) in patients (pts) with unresectable (UR) stage III epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC): Post-progression outcomes from the phase III LAURA study

Ozguroglu M., Ahn M., Dong X., Yang J., Oizumi S., Goto K., ...Daha Fazla

ANNALS OF ONCOLOGY, cilt.35, ss.1, 2024 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 35
• Basım Tarihi: 2024
• Doi Numarası: 10.1016/j.annonc.2024.10.646
• Dergi Adı: ANNALS OF ONCOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, CAB Abstracts, EMBASE, MEDLINE
• Sayfa Sayıları: ss.1
• İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır